Literature DB >> 22171686

Microphthalmia, late onset keratitis, and iris coloboma/aniridia in a family with a novel PAX6 mutation.

Xueshan Xiao, Shiqiang Li, Qingjiong Zhang.   

Abstract

Autosomal dominant microphthalmia with late-onset keratitis and iris coloboma/aniridia has not been reported before. Here we report a Chinese family with these phenotypes and a novel PAX6 mutation. Microphthalmia, late-onset keratitis, iris coloboma, and nystagmus were present in the proband. His son had microphthalmia, aniridia, foveal hypoplasia, and nystagmus. A novel c.649C>T (p.Arg217X) mutation in PAX6 was detected in the proband and his affected son. This study expands the phenotypic spectrum of PAX6 mutation and enriched our knowledge of the genetic cause for microphthalmia and late-onset keratitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171686     DOI: 10.3109/13816810.2011.642452

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  16 in total

Review 1.  Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma.

Authors:  Linda M Reis; Elena V Semina
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-03

2.  [Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care ("aniridia guide")].

Authors:  B Käsmann-Kellner; B Seitz
Journal:  Ophthalmologe       Date:  2014-12       Impact factor: 1.059

3.  Two sisters with microphthalmia and anterior segment dysgenesis secondary to a PAX6 pathogenic variant with clinically healthy parents: a case of gonadal mosaicism?

Authors:  Anna Wawrocka; Joanna Walczak-Sztulpa; Ewelina Bukowska-Olech; Aleksander Jamsheer; Marcin Jaworski; Piotr Jaworski; Maciej Robert Krawczynski
Journal:  Jpn J Ophthalmol       Date:  2020-02-03       Impact factor: 2.447

4.  Excess caffeine exposure impairs eye development during chick embryogenesis.

Authors:  Zheng-Lai Ma; Guang Wang; Xin Cheng; Manli Chuai; Hiroshi Kurihara; Kenneth Ka Ho Lee; Xuesong Yang
Journal:  J Cell Mol Med       Date:  2014-03-17       Impact factor: 5.310

5.  Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia.

Authors:  Sushil Kumar Dubey; Nagasubramanian Mahalaxmi; Perumalsamy Vijayalakshmi; Periasamy Sundaresan
Journal:  Mol Vis       Date:  2015-01-27       Impact factor: 2.367

6.  Morphometric analysis of the lens in human aniridia and mouse Small eye.

Authors:  Anna Voskresenskaya; Nadezhda Pozdeyeva; Yevgeniy Batkov; Tatyana Vasilyeva; Andrey Marakhonov; Richard A West; Jeffrey L Caplan; Ales Cvekl; Yan Wang; Melinda K Duncan
Journal:  Exp Eye Res       Date:  2020-11-26       Impact factor: 3.467

7.  PAX6 analysis of two sporadic patients from southern China with classic aniridia.

Authors:  Ying Lin; Xialin Liu; Shanshan Yu; Lixia Luo; Xuanwei Liang; Zhonghao Wang; Chuan Chen; Yi Zhu; Shaobi Ye; Hong Yan; Yizhi Liu
Journal:  Mol Vis       Date:  2012-08-07       Impact factor: 2.367

8.  Novel small-eye allele in paired box gene 6 (Pax6) is caused by a point mutation in intron 7 and creates a new exon.

Authors:  Oliver Puk; Xiaohe Yan; Sibylle Sabrautzki; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabě de Angelis; Jochen Graw
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

9.  Proanthocyanidins Prevent High Glucose-Induced Eye Malformation by Restoring Pax6 Expression in Chick Embryo.

Authors:  Rui-Rong Tan; Shi-Jie Zhang; Yi-Fang Li; Bun Tsoi; Wen-Shan Huang; Nan Yao; Mo Hong; Yu-Jia Zhai; Zhong-Fu Mao; Lu-Ping Tang; Hiroshi Kurihara; Qi Wang; Rong-Rong He
Journal:  Nutrients       Date:  2015-08-07       Impact factor: 5.717

10.  A Novel Homozygous Mutation in FOXC1 Causes Axenfeld Rieger Syndrome with Congenital Glaucoma.

Authors:  Shazia Micheal; Sorath Noorani Siddiqui; Saemah Nuzhat Zafar; Cristina Villanueva-Mendoza; Vianney Cortés-González; Muhammad Imran Khan; Anneke I den Hollander
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.